Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$2.02 - $3.92 $20,684 - $40,140
-10,240 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$3.74 - $6.7 $38,297 - $68,608
10,240 New
10,240 $38,000
Q3 2021

Nov 12, 2021

SELL
$6.05 - $10.41 $73,555 - $126,564
-12,158 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$6.66 - $10.92 $7,399 - $12,132
1,111 Added 10.06%
12,158 $120,000
Q1 2021

May 14, 2021

BUY
$4.59 - $18.74 $50,705 - $207,020
11,047 New
11,047 $103,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $509M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.